CD163 and leukemia: The relative levels of cytokine secretion strongly differ between patients and/or leukemia cell lines, which is consistent with the heterogeneity of AML genetics, phenotypes, and biology and may contribute to the variability in the expression of markers associated to HDAML-MΦ polarization, such as CD163, CD80, and CD206.